TrialDiabetes, obesity & metabolism2018

Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial.

John B Buse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.